Skip to main content
SpringerLink
Log in

Pharmacokinetic-Pharmacodynamic Modelling As Applied to Bronchial Asthma

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kroboth PD, Schmith VD, Smith RB. Pharmacodynamic modelling; application to new drug development. Clin Pharmacokinet 1991; 20: 91–8

    Article  PubMed  CAS  Google Scholar 

  2. Danhof M, Peck CC, editors. Measurement and kinetics of in vivo drug effects. 2nd International Symposium: 1994 Apr 14–16; Noordwijkerhout, The Netherlands. Leiden/Amsterdam Center for Drug Research, Leiden, 1994

  3. Van Boxtel CJ, Holford NHG, Danhof M, editors. The in vivo study of drug action. Amsterdam: Elsevier, 1992

    Google Scholar 

  4. Van Boxtel CJ, Oosterhuis B. Pharmacokinetic-pharmacodynamic modelling of glucocorticosteroid action. In: van Boxtel CJ, Holford NHG, Danhof M, editors. The in vitro study of drug action. Amsterdam: Elsevier, 1992: 357–75

    Google Scholar 

  5. Morgan DJ. Clinical pharmacokinetics of beta-agonists. Clin Pharmacokinet 1990; 18: 270–94

    Article  PubMed  CAS  Google Scholar 

  6. Taburet A, Schmit B. Pharmacokinetic optimization of asthma treatment. Clin Pharmacokinet 1994; 26: 396–418

    Article  PubMed  CAS  Google Scholar 

  7. Oosterhuis B, Braat MCP, Roos CM, et al. Pharmacokinetic-pharmacodynamic modelling of terbutaline bronchodilation in asthma. Clin Pharmacol Ther 1986; 40: 469–75

    Article  PubMed  CAS  Google Scholar 

  8. Van den Berg BTJ, Braat MCP, Koolen MGJ, et al. PK/PD modelling of the combined eosinopenic effects of formoterol and theophylline in man. In: Danhof M, Peck CC, editors. Measurement and kinetics of in vivo drug effects; advances in simultaneous pharmacokinetic/pharmacodynamic modelling. Leiden: Leiden/Amsterdam Center for Drug Research, 1994: 73–4

    Google Scholar 

  9. Derks MGM, v.d. Berg BTJ, v.d. Zee JS, et al. Different kinetic/dynamic profiles for pulmonary and orally absorbed formoterol. Abstracts of the Spring Meeting of the Dutch Society of Clinical Pharmacology and Biopharmacy, Tilburg, March 1995

  10. Midander J. Clinical documentation of inflammation markers in asthma. Clin Exp Allergy 1993; 23 (Suppl. 2): 13–4

    Article  PubMed  Google Scholar 

  11. Scheinin M, Koulu M, Laurikainen H. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol 1987; 24: 645–53

    Article  PubMed  CAS  Google Scholar 

  12. Wong CS, Pavord ID, Williams J, et al. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in astma. Lancet 1990; 336: 1396–9

    Article  PubMed  CAS  Google Scholar 

  13. Walker SR, Evans ME, Richards AJ, et al. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 1972; 13: 861–7

    PubMed  CAS  Google Scholar 

  14. Hörnblad Y, Ripe E, Magnusson PO, et al. The metabolism and clinical activity of terbutaline and its prodrug ibuterol. Eur J Clin Pharmacol 1976; 10: 9–18

    Article  Google Scholar 

  15. Van den Berg W, Leferink JG, et al. Correlation between terbutaline serum levels, c-AMP plasma levels and FEV1 in normals and asthmatics after subcutaneous administration. Ann Allergy 1980; 44: 235–9

    Google Scholar 

  16. Fairfax AJ, McNabb WR, Davies HJ, et al. Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels. Thorax 1980; 35: 526–30

    Article  PubMed  CAS  Google Scholar 

  17. Morgan DJ, Pauli JD, Richmond BH, et al. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol 1986; 22: 587–93

    Article  PubMed  CAS  Google Scholar 

  18. Holford NHG, Sheiner LB. Kinetics of pharmacological response. Pharmacol Ther 1982; 16: 143–66

    Article  PubMed  CAS  Google Scholar 

  19. Braat MCP, Jonkers RE, van Boxtel CJ. Quantification of metoprolol beta-2-adrenoceptor antagonism in asthmatic patients by pharmacokinetic-pharmacodynamic modelling. Pulmon Pharmacol 1992; 5: 31–8

    Article  CAS  Google Scholar 

  20. Fuglsang G, Pedersen S, Borgström L. Dose-response relationship of intravenously administrated terbutaline in children with asthma. J Pediatr 1989; 114: 315–20

    Article  PubMed  CAS  Google Scholar 

  21. Hochhaus G, Schmidt E-W, Rominger KL, et al. Pharmacokinetic/dynamic correlation of pulmonary and cardiac effects of fenoterol in asthmatic patients after different routes of administration. Pharm Res 1992; 9: 291–7

    Article  PubMed  CAS  Google Scholar 

  22. Hochhaus G, Mollmann H. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol. Int J Clin Pharmacol Ther Toxicol 1992; 30: 342–62

    PubMed  CAS  Google Scholar 

  23. Jonkers R, van Boxtel CJ, Oosterhuis B. Beta-2-adrenoceptor-mediated hypokalemia and its abolishment by oxprenolol. Clin Pharmacol Ther 1987; 42: 627–33

    Article  PubMed  CAS  Google Scholar 

  24. Van den Berg W, Leferink JG, Tabingh Suermondt W, et al. Terbutaline serum concentrations related to different lung function parameters and beta-receptor function. Int J Clin Pharmacol Ther Toxixcol 1983; 21: 24–30

    Google Scholar 

  25. Littenberg B. Aminophylline treatment in severe acute asthma. A meta-analysis. JAMA 1988; 259: 1678–84

    Article  PubMed  CAS  Google Scholar 

  26. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for a reappraisal? Eur Respir J 1994; 7: 579–91

    Article  PubMed  CAS  Google Scholar 

  27. Braat MCP, Jonkers RE, Bel EH, et al. Quantification of theophylline-induced eosinopenia and hypokalaemia in healthy volunteers. Clin Pharmacokinet 1992; 22: 231–7

    Article  PubMed  CAS  Google Scholar 

  28. Holford N, Black P, Couch R, et al. Theophylline target concentration in severe airways obstruction — 10 or 20 mg/L? Clin Pharmacokinet 1993; 25: 495–505

    Article  PubMed  CAS  Google Scholar 

  29. Holford N, Hashimoto Y, Sheiner LB. Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Clin Pharmacokinet 1993; 25: 506–15

    Article  PubMed  CAS  Google Scholar 

  30. Mitenko PA, Ogilvie RI. Rational intravenous doses of theophylline. N Engl J Med 1973; 289: 600–3

    Article  PubMed  CAS  Google Scholar 

  31. Whiting B, Kelman AW, Barclay J, et al. Modelling theophylline response in individual patients with chronic bronchitis. Br J Clin Pharmacol 1981; 12: 481–7

    Article  PubMed  CAS  Google Scholar 

  32. Whiting B, Kelman AW, Struthers AD. Prediction of response to theophylline in chronic bronchitis. Br J Clin Pharmacol 1984; 17: 1–8

    Article  PubMed  CAS  Google Scholar 

  33. Kong A, Ludwig EA, Slaughter RL, et al. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin Pharmacol Ther 1989; 46: 616–28

    Article  PubMed  CAS  Google Scholar 

  34. Koopmans RP, Braat MCP, Oosterhuis B, et al. Time-dependent effects of dexamethasone administration on the suppression of plasma hydrocortisone, assessed with a pharmacokinetic model. J Pharmacol Exp Ther 1992; 262: 503–8

    PubMed  CAS  Google Scholar 

  35. Oosterhuis B, ten Berge RJM, Sauerwein HP, et al. Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in man. J Pharmacol Exp Ther 1984; 229, 539–46

    PubMed  CAS  Google Scholar 

  36. Braat MCP, Jonkers RE, Koopmans RP, et al. Failing restoration of down-regulated beta-2-adrenoceptors 12 hours after 100 mg prednisone p.o.; pharmacokinetic-pharmacodynamic modelling of terbutaline-induced hypokalaemia in healthy volunteers [abstract]. Eur Respir J 1992; 5 Suppl. 15: 115

    Google Scholar 

  37. Wald JA, Salazar H, Cheng H, et al. Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics. J Pharmacokinet Biopharm 1991; 19: 521–36

    PubMed  CAS  Google Scholar 

  38. Oosterhuis B, ten Berge RJM, Schellekens PTA, et al. Prednisolone concentration-effect relations in man and the influence of plasma hydrocortisone. J Pharmacol Exp Ther 1986; 239: 919–27

    PubMed  CAS  Google Scholar 

  39. Oosterhuis B, ten Berge RJM, Schellekens PTA, et al Concentration dependent effects of prednisolone on lymphocyte subsets and MLC in man. J Pharmacol Exp Ther 1987; 243: 716–22

    PubMed  CAS  Google Scholar 

  40. Bloemena E, Koopmans RP, Weinreich S, et al. Pharmacodynamic modelling of lymphocytopenia and whole blood lymphocyte cultures in prednisolone-treated individuals. Clin Immunol Immunopathol 1990; 57: 374–86

    Article  PubMed  CAS  Google Scholar 

  41. Braat MCP, Oosterhuis B, Koopmans RP, et al. Kinetic-dynamic modelling of lymphocytopenia induced by the combined action of dexamethasone and hydrocortisone in humans, after inhalation and intravenous administration of dexamethasone. J Pharmacol Exp Ther 1992; 262: 509–15

    PubMed  CAS  Google Scholar 

  42. Dayneka NL, Garg V, Jusko WJ. Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 1993; 21: 457–78

    PubMed  CAS  Google Scholar 

  43. Holford NHG, Clements P, Collier P, et al. Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patients. Eur J Clin Pharmacol 1987; 33: 237–42

    Article  PubMed  CAS  Google Scholar 

  44. Billing B, Dahlquist R, Garle M, et al. Separate and combined use of terbutaline and theophylline in asthmatics; effects related to plasma levels. Eur J RespirDis 1982; 63: 399–409

    CAS  Google Scholar 

  45. Klein JJ, Lefcowitz MS, Spector SL, et al. Relationship between serum theophylline levels and pulmonary function before and after inhaled beta-agonist in ‘stable’ asthmatics. Am Rev Respir Dis 1983; 127: 413–6

    PubMed  CAS  Google Scholar 

  46. Lipworth BJ, Brown RA, McDevitt DG. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta-2-adrenoceptor blockade. Br J Clin Pharmacol 1989; 28: 95–102

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology and Pharmacotherapy, Department of Pulmonology, Academic Medical Centre, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

    Richard P. Koopmans & Chris J. van Boxtel

  2. Department of Pulmonology, Academic Medical Centre, Amsterdam, The Netherlands

    René E. Jonkers & M. C. Paul Braat

Authors
  1. Richard P. Koopmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. René E. Jonkers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. C. Paul Braat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chris J. van Boxtel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koopmans, R.P., Jonkers, R.E., Braat, M.C.P. et al. Pharmacokinetic-Pharmacodynamic Modelling As Applied to Bronchial Asthma. Clin-Pharmacokinet 29, 213–220 (1995). https://doi.org/10.2165/00003088-199529040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199529040-00001

Keywords

Search

Navigation